Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future
It has been seventy years since a water-soluble version of vitamin E called tocophersolan (also known as TPGS) was produced; it was approved by USFDA in 1998 as an inactive ingredient. Drug formulation developers were initially intrigued by its surfactant qualities, and gradually it made its way int...
Saved in:
Main Authors: | Abhishesh Kumar Mehata (Author), Aseem Setia (Author), Vikas (Author), Ankit Kumar Malik (Author), Rym Hassani (Author), Hamad Ghaleb Dailah (Author), Hassan A. Alhazmi (Author), Ahmed A. Albarraq (Author), Syam Mohan (Author), Madaswamy S. Muthu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
by: Natasha Manners, et al.
Published: (2022) -
Biodegradable Electrospun Scaffolds as an Emerging Tool for Skin Wound Regeneration: A Comprehensive Review
by: Deepika Sharma, et al.
Published: (2023) -
Investigating the Outcomes of an Asthma Educational Program and Useful Influence in Public Policy
by: Hamad Ghaleb Dailah
Published: (2021) -
Nanotheranostics to target antibiotic-resistant bacteria: Strategies and applications
by: Rahul Bhattacharjee, et al.
Published: (2023) -
Nanotheranostics: For P4 medicine
by: Suchetha N Malleshi
Published: (2017)